Partial lesion of the dopaminergic innervation of the ventral striatum induces "depressive-like" behavior of rats

Pharmacological Reports

Volumn 63, Issue 6, 2011, Pages 1383-1392

  Kuter, Katarzyna ^a   Kolasiewicz, Wacław ^a   Gołembiowska, Krystyna ^a   Dziubina, Anna ^a   Schulze, Gert ^b   Berghauzen, Klemencja ^a   Wardas, Jadwiga ^a   Ossowska, Krystyna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

6 OHDA; Depression; Forced swimming test; Parkinson's disease; Rat; Ventral striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANATOMICAL VARIATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRAIN DAMAGE; BRAIN FUNCTION; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DOPAMINERGIC SYSTEM; FORCED SWIMMING TEST; FRONTAL CORTEX; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INNERVATION; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PUTAMEN; RAT; SUBSTANTIA NIGRA;

EID: 84857496815     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/s1734-1140(11)70702-2     Document Type: Article

References (36)

1. Berendse HW, Groenewegen HJ, Lohman AHM: Compartmental distribution of ventral striatal neurons projecting to the mesencephalon in the rat. J Neurosci, 1992, 12, 2079-2103.
2. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K: Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res, 2004, 318, 121-134. (Pubitemid 39362633)
3. Branchi I, D'Andrea I, Armida M, Cassano T, Pèzzola A, Potenza RL, Morgese MG et al.: Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model. J Neurosci Res, 2008, 86, 2050-2061.
4. Brooks D, Piccini P: Imaging in Parkinson's disease: the role of monoamines in behavior. Biol Psychiatry, 2006, 59, 908-918.
5. Carman LS, Gage FH, Shults CW: Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res, 1991, 553, 275-283.
6. Castaneda E, Whishaw IQ, Robinson TE: Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J Neurosci, 1990, 10, 1847-1854.
7. Cryan JF, Valentino RJ, Lucki I: Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev, 2005, 29, 547-569. (Pubitemid 40755456)
8. Cummings JL: Depression and Parkinson's disease: a review. Am J Psychiatry, 1992, 149, 443-454.
9. Deumens R, Blokland A, Prickaerts J: Modelling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol, 2002, 175, 303-317. (Pubitemid 34634286)
10. Ehringer H, Hornykiewicz O: Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extra-pyramidalen Systems. Klin Wochenschr, 1960, 38, 1236-1239.
11. Fang F, Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A et al.: Depression and the subsequent risk of Parkinson's disease in the NIH-AARP diet and healthy study. Mov Disord, 2010, 25, 1157-1162.
12. Groenewegen HJ: The ventral striatum as an interface between the limbic and motor systems. CNS Spectr, 2007, 12, 887-892.
13. Gutiérrez-Garcia AG, Contreras CM, Diaz-Meza JL, Bernal-Morales B, Rodriguez-Landa JF, Saavedra M: Intraaccumbens dopaminergic lesion suppresses desipramine effects in the forced swim test but not in the neuronal activity of lateral septal nucleus. Prog Neuropsychopharmacol Biol Psychiatry, 2003, 27, 809-818. (Pubitemid 36966763)
14. Kryzhanovskii GN, Krupina NA, Kucherianu VG: A new model of an experimental depressive syndrome in rats induced by the systemic administration to the animals of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Russian). Zh Vyssh Nerv Deiat Im I Pavlova, 1995, 45, 377-387.
15. Mayeux R: Depression in the patient with Parkinson's disease. J Clin Psychiatry, 1990, 51, Suppl, 20-23.
16. Nilsson FM, Kessing LV, Bolwig TG: Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr Scand, 2001, 104, 380-386. (Pubitemid 34280555)
17. Pĺlhagen SE, Carlsson M, Curman E, Wĺlinder J, Granérus A-K: Depressive illness in Parkinson's disease - indication of a more advanced and widespread neurodegenerative process. Acta Neurol Scand, 2008, 117, 295-304.
18. Pankova NB, Krupina NA, Orlova IN, Khlebnikova NN, Kryzhanovskii GN: Involvement of brain dopaminergic systems in the development of an MPTP-induced depressive state in rats. Neurosci Behav Physiol, 2008, 38, 383-391.
19. th edition. Elsevier; Amsterdam, 2007.
20. Pellicano C, Benincasa D, Pisani V, Buttarelli FR, Giovannelli M, Pontieri FE: Prodromal non-motor symptoms of Parkinson's disease. Neuropsychiat Dis Treat, 2007, 3, 145-151. (Pubitemid 46779927)
21. Politis M, Wu K, Loane C, Turkheimer FE, Molly S, Brooks DJ, Piccini P: Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology, 2010, 75, 1920-1927.
22. Porsolt RD, Anton G, Blavet N, Jalfre M: Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol, 1978, 47, 379-391.
23. Porsolt RD, Le Pichon M, Jalfre M: Depression: a new animal model sensitive to antidepressant treatments. Nature, 1977, 266, 730-732. (Pubitemid 8073804)
24. Rektorova I, Srovnalova H, Kubikova R, Prasek J: Striatal dopamine transporter imaging correlates with depressive symptoms and Tower of London task performance in Parkinson's disease. Mov Dis, 2008, 23, 1580-1587.
25. Remy P, Doder M, Lees A, Turjanski N, Brooks D: Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain, 2005, 128, 1314-1322. (Pubitemid 40826185)
26. Santiago RM, Barbieiro J, Lima MMS, Dombrowski PA, Andreatini R, Vital MABF: Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine. Prog Neuropsychopharmacol Biol Psychiatry, 2010, 34, 1104-1114.
27. Schrag A: Psychiatric aspects of Parkinson's disease. An update. J Neurol, 2004, 251, 795-804.
28. Schuurman AG, van den Akker M, Ensinck KT, Metsemakers JF, Knottnerus JA, Leentjens AF, Buntinx F: Increased risk of Parkinson's disease after depression; a retrospective cohort study. Neurology, 2002, 58, 1501-1504. (Pubitemid 34552956)
29. Tadaiesky MT, Dombrowski PA, Fugueiredo CP, Cargnin-Ferreira E, Da Cunha C, Takahashi RN: Emotional cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease. Neuroscience, 2008, 156, 830-840.
30. Tandberg E, Larsen JP, Aarsland D, Cummings JL: The occurrence of depression in Parkinson's disease: a community-based study. Arch Neurol, 1996, 53, 175-179. (Pubitemid 26055265)
31. Tissingh G, Bergmans P, Booij J, Winogrodzka A, van Royen EA, Stoof JC, Wolters EC: Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I] β-CIT SPECT. J Neurol, 1998, 245, 14-20. (Pubitemid 28118855)
32. Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AGM, van Royen EA, Stoof JC, Wolters EC: Iodine-123-N-ω-fluoropropyl-2β- carbomethoxy-3β-(4-iodophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease. J Nucl Med, 1998, 39, 1143-1148. (Pubitemid 28326141)
33. Voorn P, Vanderschuren LJMJ, Groenewegen HJ, Robbins TW, Pennartz CMA: Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci, 2004, 27, 468-474. (Pubitemid 38951039)
34. 6 receptor in depression and anxiety: an overview of preclinical data. Pharmacol Rep, 2010, 62, 564-577.
35. Winter C, von Rumohr A, Mundt A, Petrus D, Klein J, Lee T, Morgenstern R et al.: Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats. Behav Brain Res, 2007, 184, 133-141. (Pubitemid 47498601)
36. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM: Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci, 1990, 13, 290-296. (Pubitemid 20193461)